Pfizer seeks approval for COVID vaccine for kids

Pfizer and BioNTech have asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged five to 11, and the vaccine could be ready for roll out as early as November, according to the White House. This report produced by Jillian Kitchener.